Drugs / Qing Re He Ji
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06520618 | Feb 2023 → Feb 2024 | respiratory tract infectious disorder | Shengjing Hospital | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Qing Re He Ji | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06520618 ↗ |
| Known as | QRHJ | “Qing Re He Ji (QRHJ; heat-clearing mixture), a TCM compound developed by our hospital” NCT06520618 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “a TCM compound developed by our hospital” NCT06520618 ↗ |
| Route | Oral | “Oral administration of Qing Re He Ji” NCT06520618 ↗ |